Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of raltegravir intensification on HIV-1 viral latency in patients with complete viral suppression
2007-003801-28Phase 3Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Started Sep 2007; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003801-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003801-28.